These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 14974086)

  • 1. Analysis of CBP (CREBBP) gene deletions in Rubinstein-Taybi syndrome patients using real-time quantitative PCR.
    Coupry I; Monnet L; Attia AA; Taine L; Lacombe D; Arveiler B
    Hum Mutat; 2004 Mar; 23(3):278-84. PubMed ID: 14974086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations.
    Petrij F; Dauwerse HG; Blough RI; Giles RH; van der Smagt JJ; Wallerstein R; Maaswinkel-Mooy PD; van Karnebeek CD; van Ommen GJ; van Haeringen A; Rubinstein JH; Saal HM; Hennekam RC; Peters DJ; Breuning MH
    J Med Genet; 2000 Mar; 37(3):168-76. PubMed ID: 10699051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP.
    Petrij F; Giles RH; Dauwerse HG; Saris JJ; Hennekam RC; Masuno M; Tommerup N; van Ommen GJ; Goodman RH; Peters DJ
    Nature; 1995 Jul; 376(6538):348-51. PubMed ID: 7630403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rubinstein-Taybi syndrome caused by a De Novo reciprocal translocation t(2;16)(q36.3;p13.3).
    Petrij F; Dorsman JC; Dauwerse HG; Giles RH; Peeters T; Hennekam RC; Breuning MH; Peters DJ
    Am J Med Genet; 2000 May; 92(1):47-52. PubMed ID: 10797422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptic microdeletion of the CREBBP gene from t(1;16) (p36.2;p13.3) as a novel genetic defect causing Rubinstein-Taybi syndrome.
    Kim SR; Kim HJ; Kim YJ; Kwon JY; Kim JW; Kim SH
    Ann Clin Lab Sci; 2013; 43(4):450-6. PubMed ID: 24247805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for partial deletions in the CREBBP gene in Rubinstein-Taybi syndrome patients using multiplex PCR/liquid chromatography.
    Udaka T; Kurosawa K; Izumi K; Yoshida S; Tsukahara M; Okamoto N; Torii C; Kosaki R; Masuno M; Hosokai N; Takahashi T; Kosaki K
    Genet Test; 2006; 10(4):265-71. PubMed ID: 17253932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Submicroscopic deletion of chromosome 16p13.3 in patients with Rubinstein-Taybi syndrome.
    Taine L; Goizet C; Wen ZQ; Petrij F; Breuning MH; Aymé S; Saura R; Arveiler B; Lacombe D
    Am J Med Genet; 1998 Jul; 78(3):267-70. PubMed ID: 9677064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of CREBBP gene dosage anomalies in Rubinstein-Taybi syndrome patients.
    Stef M; Simon D; Mardirossian B; Delrue MA; Burgelin I; Hubert C; Marche M; Bonnet F; Gorry P; Longy M; Lacombe D; Coupry I; Arveiler B
    Eur J Hum Genet; 2007 Aug; 15(8):843-7. PubMed ID: 17473832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FISH studies in 45 patients with Rubinstein-Taybi syndrome: deletions associated with polysplenia, hypoplastic left heart and death in infancy.
    Bartsch O; Wagner A; Hinkel GK; Krebs P; Stumm M; Schmalenberger B; Böhm S; Balci S; Majewski F
    Eur J Hum Genet; 1999; 7(7):748-56. PubMed ID: 10573006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplex ligation-dependent probe amplification detection of an unknown large deletion of the CREB-binding protein gene in a patient with Rubinstein-Taybi syndrome.
    Calì F; Failla P; Chiavetta V; Ragalmuto A; Ruggeri G; Schinocca P; Schepis C; Romano V; Romano C
    Genet Mol Res; 2013 Jan; 12(3):2809-15. PubMed ID: 23315884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome.
    Kalkhoven E; Roelfsema JH; Teunissen H; den Boer A; Ariyurek Y; Zantema A; Breuning MH; Hennekam RC; Peters DJ
    Hum Mol Genet; 2003 Feb; 12(4):441-50. PubMed ID: 12566391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a 1.2-Mb contig surrounding, and molecular analysis of, the human CREB-binding protein (CBP/CREBBP) gene on chromosome 16p13.3.
    Giles RH; Petrij F; Dauwerse HG; den Hollander AI; Lushnikova T; van Ommen GJ; Goodman RH; Deaven LL; Doggett NA; Peters DJ; Breuning MH
    Genomics; 1997 May; 42(1):96-114. PubMed ID: 9177780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rubinstein-Taybi syndrome caused by submicroscopic deletions within 16p13.3.
    Breuning MH; Dauwerse HG; Fugazza G; Saris JJ; Spruit L; Wijnen H; Tommerup N; van der Hagen CB; Imaizumi K; Kuroki Y; van den Boogaard MJ; de Pater JM; Mariman EC; Hamel BC; Himmelbauer H; Frischauf AM; Stallings R; Beverstock GC; van Ommen GJ; Hennekam RC
    Am J Hum Genet; 1993 Feb; 52(2):249-54. PubMed ID: 8430691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in microdeletions of the cyclic AMP-responsive element-binding protein gene at chromosome band 16p13.3 in the Rubinstein-Taybi syndrome.
    Blough RI; Petrij F; Dauwerse JG; Milatovich-Cherry A; Weiss L; Saal HM; Rubinstein JH
    Am J Med Genet; 2000 Jan; 90(1):29-34. PubMed ID: 10602114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patients.
    Bentivegna A; Milani D; Gervasini C; Castronovo P; Mottadelli F; Manzini S; Colapietro P; Giordano L; Atzeri F; Divizia MT; Uzielli ML; Neri G; Bedeschi MF; Faravelli F; Selicorni A; Larizza L
    BMC Med Genet; 2006 Oct; 7():77. PubMed ID: 17052327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism.
    Oike Y; Hata A; Mamiya T; Kaname T; Noda Y; Suzuki M; Yasue H; Nabeshima T; Araki K; Yamamura K
    Hum Mol Genet; 1999 Mar; 8(3):387-96. PubMed ID: 9949198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of mosaic CREBBP deletions in Rubinstein-Taybi syndrome patients and mapping of somatic and germ-line breakpoints.
    Gervasini C; Castronovo P; Bentivegna A; Mottadelli F; Faravelli F; Giovannucci-Uzielli ML; Pessagno A; Lucci-Cordisco E; Pinto AM; Salviati L; Selicorni A; Tenconi R; Neri G; Larizza L
    Genomics; 2007 Nov; 90(5):567-73. PubMed ID: 17855048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS.
    Bartsch O; Schmidt S; Richter M; Morlot S; Seemanová E; Wiebe G; Rasi S
    Hum Genet; 2005 Sep; 117(5):485-93. PubMed ID: 16021471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome.
    Murata T; Kurokawa R; Krones A; Tatsumi K; Ishii M; Taki T; Masuno M; Ohashi H; Yanagisawa M; Rosenfeld MG; Glass CK; Hayashi Y
    Hum Mol Genet; 2001 May; 10(10):1071-6. PubMed ID: 11331617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype correlations in Rubinstein-Taybi syndrome.
    Schorry EK; Keddache M; Lanphear N; Rubinstein JH; Srodulski S; Fletcher D; Blough-Pfau RI; Grabowski GA
    Am J Med Genet A; 2008 Oct; 146A(19):2512-9. PubMed ID: 18792986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.